- Louvet previously held the role of senior associate within Stanley Capital’s investment team
- Louvet has worked closely with SCP’s portfolio company LXO Group
- SCP is a European mid-market private equity firm based in London
Stanley Capital Partners (SCP) has promoted Rodolphe Louvet to Principal.
Louvet previously held the role of senior associate within SCP’s investment team and has worked closely with the firm’s portfolio company, LXO Group.
Louvet had a “significant” role in the acquisition of the prescription drug Nimodipine (under the brand name Nimotop) from Bayer, according to a press statement.
The promotion is Louvet’s second in 2 years since he started as an associate at SCP in 2022.
SCP is a European mid-market private equity firm that targets businesses with the potential of generating EBITDA of $25 million to $150 million. It is based in London.